| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2022―Aug―01 |
Coronavirus disease 2019, hypertension, and renin-angiotensin-aldosterone system inhibitors |
John G. Rizk, Fabian Sanchis-Gomar, Brandon M. Henry, Giuseppe Lippi, Carl J. Lavie |
| 2 |
[GO] |
2022―Jun―22 |
Coronavirus disease 2019 and the cardiologist |
Khan O. Mohammad, Jose B. Cruz Rodriguez, Marcus A. Urey |
| 3 |
[GO] |
2021―Mar―12 |
Coronavirus disease 2019 |
Zhiyi Qiang, Bing Wang, Brenda C. Garrett, R. Patrick Rainey, Harold Robert Superko |
| 4 |
[GO] |
2021―Mar―03 |
Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes |
Yeabsra Kefyalew Aleligne, Duke Appiah, Imo A. Ebong |
| 5 |
[GO] |
2021―Feb―27 |
Cardiovascular complications of COVID-19 |
Ali J. Marian |
| 6 |
[GO] |
2021―Jan―01 |
Cardiovascular implications and complications of the coronavirus disease-2019 pandemic |
Antonis S. Manolis, Theodora A. Manolis, Antonis A. Manolis, Helen Melita |
| 7 |
[GO] |
2020―Dec―28 |
COVID-19 myocarditis and long-term heart failure sequelae |
Jing Liu, Anita Deswal, Umair Khalid |
| 8 |
[GO] |
2020―Nov―02 |
COVID-19 will forever change the landscape of telemedicine |
Emmie Cohen, Mitchell I. Cohen |
| 9 |
[GO] |
2020―May―12 |
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill? |
Christopher N. Floyd, Anthony S. Wierzbicki |
